Natriuretic peptides as a prognostic marker and therapeutic target in heart failure

Heart

Volumn 92, Issue 2, 2006, Pages 149-151

  Wright, Gary A ^a   Struthers, A D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

ACUTE CORONARY SYNDROME; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; EDITORIAL; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS;

BIOLOGICAL MARKERS; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDES; PROGNOSIS;

EID: 31144463677     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.018325     Document Type: Editorial

References (18)

1. Anand IS, Fisher LD, Chiang Y-T, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality in the valsartan heart failure trial (Val-HeFT). Circulation 2003;107:1278-83.
2. Omland T, Aakvaag A, Bonarjee VVS, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and longterm survival after myocadial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996;93:1963-9.
3. Tsutamoto T, Wada A, Maeda K. Effects of spironolactone on plasma brain natriuretic peptide and left ventricular remodelling in patients with congestive heart failure. J Am Coll Cardiol 2001;37:1228-33.
4. McDonagh TA, Cunningham AD, Morrison CE, et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 2001;86:21-6.
5. Tsutamoto T, Wada A, Maeda K, et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Eur Heart J 1999;20:1799-807.
6. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
7. Murdoch D, McDonagh T, Byrne J, et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 1999;138:1126-32.
8. Dahle TG, Miller LW. Using changes in B-type natriuretic peptide levels between hospital admission and discharge to predict mortality of patients with heart failure [abstract]. J Am Coll Cardiol 2005;45:138A.
9. Wallen T, Landahl S, Hedner T, et al. Brain natriuretic peptide predicts mortality in the elderly. Heart 1997;77:264-7.
10. Troughton RW, Frampton C, Yandle TG, et al. Treatment in heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-30.
11. Cheng V, Kazanegra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001;37:386-91.
12. Troughton RW, Frampton C, Yandle TG, et al. Treatment in heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-30.
13. Jourdain P, Funck F, Gueffet P, et al. Benefit of BNP plasma levels for optimising therapy: the systolic heart failure treatment supported by BNP multicenter randomised trial (STARS-BNP) [abstract]. J Am Coll Cardiol 2005;45:3A.
14. Mancini DM, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778.
15. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877.
16. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002;105:2392-7.
17. Klingenberg R, Zuhck C, Becker R, et al. Elevated B-type natriuretic peptide is associated with ventricular tachyarrhythmic events determined by ICD interrogation in congestive heart failure patients [abstract]. J Am Coll Cardiol 2005,45:110A.
18. Gardner R, Ozalp F, Murday A, et al. N-terminal brain natriuretic peptide: the new gold standard in predicting mortality in patients with advanced heart failure [abstract]. J Am Coll Cardiol 2003;41:141A.